Singarayakonda student tragedy, highlighting the need for a fair investigation, school management's right to due process, and justice based on evidence rather than allegations.
Shares of Symbiotec Pharmalab made a lukewarm debut, listing largely flat on the bourses. The stock opened at its IPO price of Rs 988 apiece on the NSE
The biopharmaceutical and biotechnology company Symbiotec Pharmalab is set to tap the capital markets with an initial public offering (IPO) worth Rs 1,757 crore. The company has fixed the price band at Rs 938 Rs 988 per share, with the issue opening for subscr
